Literature DB >> 22474204

Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003-2009.

Peter K Lindenauer1, Tara Lagu, Meng-Shiou Shieh, Penelope S Pekow, Michael B Rothberg.   

Abstract

CONTEXT: Recent reports suggest that the mortality rate of patients hospitalized with pneumonia has steadily declined. While this may be the result of advances in clinical care or improvements in quality, it may also represent an artifact of changes in diagnostic coding.
OBJECTIVE: To compare estimates of trends in hospitalizations and inpatient mortality among patients with pneumonia using 2 approaches to case definition: one limited to patients with a principal diagnosis of pneumonia, and another that includes patients with a secondary diagnosis of pneumonia if the principal diagnosis is sepsis or respiratory failure. DESIGN, SETTING, AND PARTICIPANTS: Trends study using data from the 2003-2009 releases of the Nationwide Inpatient Sample. MAIN OUTCOME MEASURES: Change in the annual hospitalization rate and change in inpatient mortality over time.
RESULTS: From 2003 to 2009, the annual hospitalization rate for patients with a principal diagnosis of pneumonia declined 27.4%, from 5.5 to 4.0 per 1000, while the age- and sex-adjusted mortality decreased from 5.8% to 4.2% (absolute risk reduction [ARR], 1.6%; 95% CI, 1.4%-1.9%; relative risk reduction [RRR], 28.2%; 95% CI, 25.2%-31.2%). Over the same period, hospitalization rates of patients with a principal diagnosis of sepsis and a secondary diagnosis of pneumonia increased 177.6% from 0.4 to 1.1 per 1000, while inpatient mortality decreased from 25.1% to 22.2% (ARR, 3.0%; 95% CI, 1.6%-4.4%; RRR, 12%; 95% CI, 7.5%-16.1%); hospitalization rates for patients with a principal diagnosis of respiratory failure and a secondary diagnosis of pneumonia increased 9.3% from 0.44 to 0.48 per 1000 and mortality declined from 25.1% to 19.2% (ARR, 6.0%; 95% CI, 4.6%-7.3%; RRR, 23.7%; 95% CI, 19.7%-27.8%). However, when the 3 groups were combined, the hospitalization rate declined only 12.5%, from 6.3 to 5.6 per 1000, while the age- and sex-adjusted inpatient mortality rate increased from 8.3% to 8.8% (AR increase, 0.5%; 95% CI, 0.1%-0.9%; RR increase, 6.0%; 95% CI, 3.3%-8.8%). Over this same time frame, the age-, sex-, and comorbidity-adjusted mortality rate declined from 8.3% to 7.8% (ARR, 0.5%; 95% CI, 0.2%-0.9%; RRR, 6.3%; 95% CI, 3.8%-8.8%).
CONCLUSIONS: From 2003 to 2009, hospitalization and inpatient mortality rates for patients with a principal diagnosis of pneumonia decreased substantially, whereas hospitalizations with a principal diagnosis of sepsis or respiratory failure accompanied by a secondary diagnosis of pneumonia increased and mortality declined. However, when the 3 pneumonia diagnoses were combined, the decline in the hospitalization rate was attenuated and inpatient mortality was little changed, suggesting an association of these results with temporal trends in diagnostic coding.

Entities:  

Mesh:

Year:  2012        PMID: 22474204     DOI: 10.1001/jama.2012.384

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  137 in total

1.  Burden and spectrum of infectious disease in Germany 2009-2014: a multicentre study from Berlin's Municipal Hospitals.

Authors:  Juri Katchanov; Kai Wöstmann; Daniela Tominski; Laura Jefferys; Anna Liedtke; Arnim Schneider; Hortense Slevogt; Keikawus Arastéh; Hartmut Stocker
Journal:  Infection       Date:  2015-08-27       Impact factor: 3.553

2.  Disease-Specific Trends of Comorbidity Coding and Implications for Risk Adjustment in Hospital Administrative Data.

Authors:  Ulrike Nimptsch
Journal:  Health Serv Res       Date:  2015-10-07       Impact factor: 3.402

3.  Can we make performance measures more resilient to the effects of coding?

Authors:  Tara Lagu; Peter Lindenauer
Journal:  Crit Care Med       Date:  2015-05       Impact factor: 7.598

4.  Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia.

Authors:  Barbara Ellen Jones; Jian Ying; Vanessa Stevens; Candace Haroldsen; Tao He; McKenna Nevers; Matthew A Christensen; Richard E Nelson; Gregory J Stoddard; Brian C Sauer; Peter M Yarbrough; Makoto M Jones; Matthew Bidwell Goetz; Tom Greene; Matthew H Samore
Journal:  JAMA Intern Med       Date:  2020-04-01       Impact factor: 21.873

5.  Mortality Measures to Profile Hospital Performance for Patients With Septic Shock.

Authors:  Allan J Walkey; Meng-Shiou Shieh; Vincent X Liu; Peter K Lindenauer
Journal:  Crit Care Med       Date:  2018-08       Impact factor: 7.598

6.  Liberal Versus Restrictive Intravenous Fluid Therapy for Early Septic Shock: Rationale for a Randomized Trial.

Authors:  Wesley H Self; Matthew W Semler; Rinaldo Bellomo; Samuel M Brown; Bennett P deBoisblanc; Matthew C Exline; Adit A Ginde; Colin K Grissom; David R Janz; Alan E Jones; Kathleen D Liu; Stephen P J Macdonald; Chadwick D Miller; Pauline K Park; Lora A Reineck; Todd W Rice; Jay S Steingrub; Daniel Talmor; Donald M Yealy; Ivor S Douglas; Nathan I Shapiro
Journal:  Ann Emerg Med       Date:  2018-05-10       Impact factor: 5.721

Review 7.  Using existing data to address important clinical questions in critical care.

Authors:  Colin R Cooke; Theodore J Iwashyna
Journal:  Crit Care Med       Date:  2013-03       Impact factor: 7.598

8.  Association of Early Do-Not-Resuscitate Orders with Unplanned Readmissions among Patients Hospitalized for Pneumonia.

Authors:  Anuj B Mehta; Colin R Cooke; Ivor S Douglas; Peter K Lindenauer; Renda Soylemez Wiener; Allan J Walkey
Journal:  Ann Am Thorac Soc       Date:  2017-01

9.  The trends in treatment of femoral neck fractures in the Medicare population from 1991 to 2008.

Authors:  Benjamin J Miller; Xin Lu; Peter Cram
Journal:  J Bone Joint Surg Am       Date:  2013-09-18       Impact factor: 5.284

10.  Functional disability, cognitive impairment, and depression after hospitalization for pneumonia.

Authors:  Dimitry S Davydow; Catherine L Hough; Deborah A Levine; Kenneth M Langa; Theodore J Iwashyna
Journal:  Am J Med       Date:  2013-03-14       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.